不同肌少症判定方法在加拿大老龄化纵向研究中识别的是同一批人吗?
该横断面研究基于加拿大老龄化纵向研究2011—2015年基线数据,纳入10,820名65至85岁社区居住老年人,比较专家小组推荐的不同肌少症判定组合之间的一致性。
要点
- 肌少症识别方式不同可能影响临床管理,需统一定义。
核心结论
- 用于判定肌少症的变量组合及多数四肢瘦体重(ALM)校正技术之间一致性不足,不能视为等价。
- 肌少症识别方式不同可能影响治疗,临床需要统一的肌少症定义。
研究设计与样本
- 加拿大老龄化纵向研究2011—2015年基线数据的横断面研究,为基于人群的多中心研究,对象为社区居住老年人。
- 符合条件者n=12,646,年龄65至85岁,居住在加拿大11个数据收集点25至50 km范围内;分析纳入具备肌少症诊断所需数据的10,820人。
主要发现
- 样本平均年龄73.0±5.6岁,男性占51.9%。
关键数值与推荐
- 肌少症操作化为四肢瘦体重(ALM)、ALM与握力、ALM与步速、握力与步速四种组合。
- 每种组合中ALM分别按身高平方、体重、体质指数、以及瘦体重对身高和脂肪质量回归的残差进行校正。
- 低ALM cutoff采用性别特异性最低第20百分位值。
临床怎么用
- 临床识别肌少症时应意识到不同判定组合与ALM校正方法可能筛出不同个体,不宜混用或直接互换结果。
- 在缺乏统一定义的情况下,应结合所用具体判定标准解读肌少症状态及其对治疗决策的影响。
局限性
- 原文摘要未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVES: Sarcopenia is associated with poor health outcomes such as disability, institutionalization, and mortality. Efforts to manage sarcopenia clinically have been hindered by challenges in determining how to ascertain sarcopenia status correctly. The objective of this project was to assess the agreement between the different methods of ascertaining sarcopenia recommended by expert groups. DESIGN: Cross-sectional study of baseline data (2011-2015) from the Canadian Longitudinal Study on Aging. SETTING: Population-based multicenter study of community-dwelling participants. PARTICIPANTS: Eligible participants (n = 12,646) aged 65 to 85 living within 25 to 50 km of 11 data collection sites in Canada. The analyses included 10,820 participants with the data required to diagnose sarcopenia. MEASUREMENTS: Sarcopenia was operationalized as appendicular lean mass (ALM), ALM and grip strength, ALM and gait speed, and grip strength and gait speed. Within each combination, ALM was adjusted for height squared, weight, body mass index, and the residual of regressing lean mass on height and fat mass. The lowest 20th sex-specific percentile values were used as the cutoffs for low ALM. Low grip strength cutoffs of 35.5 kg for men and 20 kg for women and a gait speed cutoff of .8 m/s were used. RESULTS: The mean age was 73.0 ± 5.6 years, and 51.9% of the sample was male. The agreement (Cohen's κ) between the different combinations of variables used to ascertain sarcopenia status was below .50. Agreement for the different lean mass adjustment techniques ranged from .04 to .76. CONCLUSION: The combination of variables used to ascertain sarcopenia and many of the ALM adjustment techniques have insufficient agreement to be considered equivalent. This has important clinical implications for the management of sarcopenia because treatments may differ based on how sarcopenia is identified. To improve the clinical utility of sarcopenia, a unified definition of sarcopenia is required.
引用
- Mayhew AJ, Phillips SM, Sohel N, et al. Do Different Ascertainment Techniques Identify the Same Individuals as Sarcopenic in the Canadian Longitudinal Study on Aging? J Am Geriatr Soc. 2020. PMID: 32936468. doi:10.1111/jgs.16823
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。